Melanoma driver genes, including BRAF, have been implicated in the regulation of cellular energy metabolism (Abildgaard and Guldberg, 2015), which has been shown to undergo reprogramming, being characterized by plasticity that facilitates melanoma progression and drug resistance (Alkaraki et al., 2021). Here, BRAF is linked to melanoma.